Abstract:Abstract Background Maternal smoking affects more than half a million pregnancies each year in the US and is known to result in fetal growth restriction as measured by lower birthweight and its associated long-term consequences. Maternal smoking also has been linked to altered fetal DNA methylation (DNAm). However, what remains largely unexplored is whether these DNAm alterations are merely markers of smoking exposure or if they also have implications for health outcomes. This study tested the hypothesis that fetal DNAm mediates the effect of maternal smoking on newborn birthweight. Methods This study included mother–newborn pairs from a US predominantly urban, low-income multi-ethnic birth cohort. DNAm in cord blood were determined using the Illumina Infinium MethylationEPIC BeadChip. After standard quality control and normalization procedures, an epigenome-wide association study (EWAS) of maternal smoking was performed using linear regression models, controlling for maternal age, education, race, parity, pre-pregnancy body mass index, alcohol consumption, gestational age, maternal pregestational/gestational diabetes, child sex, cord blood cell compositions and batch effects. To quantify the degree to which cord DNAm mediates the smoking-birthweight association, the VanderWeele-Vansteelandt approach for single mediator and structural equational model for multiple mediators were used, adjusting for pertinent covariates. Results The study included 954 mother–newborn pairs. Among mothers, 165 (17.3%) ever smoked before or during pregnancy. Newborns with smoking exposure had on average 258 g lower birthweight than newborns without exposure ( P < 0.001). Using a false discovery rate (FDR) < 0.05 as the significance cutoff, the EWAS identified 38 differentially methylated CpG sites associated with maternal smoking. Of those, 17 CpG sites were mapped to previously reported genes: GFI1, AHRR, CYP1A1, and CNTNAP2; 8 of those, located in the first three genes, were Bonferroni significantly associated with newborn birthweight and mediated the smoking-birthweight association. The combined mediation effect of the three genes explained 67.8% of the smoking-birthweight association. Conclusions Our study not only lends further support that maternal smoking alters fetal DNAm in a multiethnic population, but also suggests that fetal DNAm substantially mediates the maternal smoking–birthweight association. Our findings, if further validated, indicate that DNAm modification is likely an important pathway by which maternal smoking impairs fetal growth and, perhaps, even long-term health outcomes.

Epigenetic Biomarker: Improving Estimates of Fetal Exposure to Cigarette Smoke

Linking Prenatal Environmental Exposures to Lifetime Health with Epigenome-Wide Association Studies: State-of-the-Science Review and Future Recommendations

Assessment of global DNA methylation in the first trimester fetal tissues exposed to maternal cigarette smoking

Development and Validation of a Novel Placental DNA Methylation Biomarker of Maternal Smoking during Pregnancy in the ECHO Program

Metabolomics Reveals Effects of Maternal Smoking on Endogenous Metabolites from Lipid Metabolism in Cord Blood of Newborns

Investigating the DNA methylation profile of e-cigarette use

Epigenetic footprints: Investigating placental DNA methylation in the context of prenatal exposure to phenols and phthalates

Fetal Exposure to Maternal Smoking and Neonatal Metabolite Profiles

Epigenome-wide Analysis of DNA Methylation in Lung Tissue Shows Concordance with Blood Studies and Identifies Tobacco Smoke-Inducible Enhancers

Maternal caffeine intake and DNA methylation in newborn cord blood

DNA methylation mediates the effect of maternal smoking on offspring birthweight: a birth cohort study of multi-ethnic US mother–newborn pairs

Maternal smoking DNA methylation risk score associated with health outcomes in offspring of European and South Asian ancestry

Novel DNA methylation sites associated with cigarette smoking among African Americans

Maternal E-Cigarette Exposure Results in Cognitive and Epigenetic Alterations in Offspring in a Mouse Model

Placental DNA methylation and child lung function at 3-years

High-resolution epigenomic liquid biopsy for noninvasive phenotyping in pregnancy

Cigarette smoking and e-cigarette use induce shared DNA methylation changes linked to carcinogenesis

The signature of cancer methylation markers in maternal plasma: Factors influencing the development and application of cancer liquid biopsy assay

Imputed DNA methylation outperforms measured loci associations with smoking and chronological age

The association of cigarette smoking with DNA methylation and gene expression in human tissue samples

Using Nicotine in Scalp Hair to Assess Maternal Passive Exposure to Tobacco Smoke.